Cargando…
Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions
Human complement is the first line of defence against invading pathogens and is involved in tissue homeostasis. Complement-targeted therapies to treat several diseases caused by a dysregulated complement are highly desirable. Despite huge efforts invested in their development, only very few are curr...
Autores principales: | Ruiz-Molina, Natalia, Parsons, Juliana, Decker, Eva L., Reski, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957715/ https://www.ncbi.nlm.nih.gov/pubmed/36851916 http://dx.doi.org/10.1016/j.csbj.2023.02.002 |
Ejemplares similares
-
A synthetic protein as efficient multitarget regulator against complement over-activation
por: Ruiz-Molina, Natalia, et al.
Publicado: (2022) -
Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization
por: Kárpáti, Éva, et al.
Publicado: (2020) -
Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation
por: Xu, Boyang, et al.
Publicado: (2022) -
Process Engineering of Biopharmaceutical Production in Moss Bioreactors via Model-Based Description and Evaluation of Phytohormone Impact
por: Ruiz-Molina, Natalia, et al.
Publicado: (2022) -
Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation
por: Papp, Alexandra, et al.
Publicado: (2022)